Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?


Drug Profile


Alternative Names: Aipuliete™; ONO 9302; SKF 105657

Latest Information Update: 04 Dec 2003

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator GlaxoSmithKline
  • Developer China Pharmaceutical University; Jiangsu Lianhuan Pharmaceutical; Ono Pharmaceutical
  • Class Androstadienes; Antihormones; Small molecules
  • Mechanism of Action Cholestenone 5-alpha reductase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Benign prostatic hyperplasia
  • Discontinued Acne; Alopecia; Cancer

Most Recent Events

  • 15 Apr 2000 Launched for Benign prostatic hyperplasia in China (unspecified route)
  • 23 Mar 1999 Discontinued-Preclinical for Acne in USA (Unknown route)
  • 23 Mar 1999 Discontinued-Preclinical for Alopecia in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top